Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Shares Issued (2016 - 2025)

Agios Pharmaceuticals' Shares Issued history spans 14 years, with the latest figure at $2.6 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 47.19% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $8.7 million, down 39.93%, while the annual FY2025 figure was $8.7 million, 39.93% down from the prior year.
  • Shares Issued reached $2.6 million in Q4 2025 per AGIO's latest filing, down from $4.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $25.7 million in Q2 2021 to a low of $16000.0 in Q2 2022.
  • Average Shares Issued over 5 years is $3.4 million, with a median of $1.8 million recorded in 2023.
  • Peak YoY movement for Shares Issued: skyrocketed 1454.06% in 2021, then crashed 99.94% in 2022.
  • A 5-year view of Shares Issued shows it stood at $267000.0 in 2021, then plummeted by 60.67% to $105000.0 in 2022, then surged by 706.67% to $847000.0 in 2023, then soared by 471.66% to $4.8 million in 2024, then tumbled by 47.19% to $2.6 million in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Shares Issued are $2.6 million (Q4 2025), $4.4 million (Q3 2025), and $65000.0 (Q2 2025).